new eye drop for glaucoma, Alphagan (brimonidine)

October 1996

This month Allergan is launching a new eye drop for glaucoma, Alphagan (brimonidine).

Alphagan is a selective alpha-2 agonist. It lowers intraocular pressure by reducing fluid production in the eye...AND increasing its outflow.

It'll be used as an alternative for patients who can't tolerate or don't respond to topical beta-blockers (Timoptic, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote